Manipulating and modulating the B cells that are responsible for immune-mediated tissue destruction is an effective approach to the treatment of autoimmune and inflammatory diseases. But how do you know your therapies will work?
This webinar breaks down the elements of an efficient program to assess the efficacy of your immunomodulatory therapies. Learn how specific modalities and disease-relevant models can streamline your development.
Louise Brackenbury, PhD
Group Leader, Cell Biology
Manuela Cerina, PhD
Group Leader, Pharmacology
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.